Global Information
회사소개 | 문의

세계의 소화기계 의약품 시장 : 제산제, 항궤양약, 비타민 및 미네랄, 항비만약, 항구토제, 지사제

Gastrointestinal Drugs Global Market Report 2018

리서치사 The Business Research Company
발행일 2018년 02월 상품 코드 531327
페이지 정보 영문 125 Pages
가격
US $ 4,000 ₩ 4,565,600 PDF by E-mail (Single User License)
US $ 6,000 ₩ 6,848,400 PDF by E-mail (Site License)
US $ 8,000 ₩ 9,131,200 PDF by E-mail (Enterprise License)


세계의 소화기계 의약품 시장 : 제산제, 항궤양약, 비타민 및 미네랄, 항비만약, 항구토제, 지사제 Gastrointestinal Drugs Global Market Report 2018
발행일: 2018년 02월 페이지 정보 : 영문 125 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계의 소화기계 의약품 시장을 조사했으며, 시장 정의와 개요, 시장에 대한 각종 영향요인 분석, 약제 부문·지역·국가별 동향과 시장 규모 추이 및 예측, 거시경제 요인·헬스케어 시장 전체·각종 산업 지표와의 비교, 경쟁 환경, 기업 개요 등을 정리하여 전해드립니다.

제1장 시장의 특징

제2장 시장 규모·성장률

  • 시장 성장 : 현재까지의 경위
    • 성장 촉진요인
    • 성장 억제요인
  • 시장 성장 : 예측
    • 성장 촉진요인
    • 성장 억제요인

제3장 PESTLE 분석

제4장 고객 정보

제5장 소화기계 의약품 시장 분석 : 세분화별

  • 세계 시장의 실적 : 부문별
    • 제산제
    • 항궤양약
    • 비타민·미네랄
    • 항비만약
    • 항구토제
    • 지사제
  • 세계 시장의 추이와 예측 : 부문별
  • 시장 동향·전략

제6장 소화기계 의약품 시장 분석 : 지역·국가별 분석

  • 세계 시장의 실적 : 지역별
  • 세계 시장의 추이와 예측 : 지역별
  • 시장 실적 : 국가별
  • 시장의 추이와 예측 : 국가별
  • 세계 의약품 시장의 실적 : 부문·지역별
  • 세계 의약품 시장의 실적 : 부문·국가별

제7장 거시경제 요인과 시장의 비교

  • 시장 규모의 GDP에서 차지하는 비율
  • 1인당 평균 지출액

제8장 거시경제 요인과 시장의 비교 : 국가별

  • 시장 규모의 GDP에서 차지하는 비율 : 국가별
  • 1인당 평균 지출액 : 국가별

제9장 산업 지표와 시장의 비교

  • 세계의 약제사 수 : 국가별
  • 시장 매출 vs 약제사 수 : 국가별
  • 세계의 의약품회사 수 : 국가별
  • 시장 매출 vs 의약품회사 수 : 국가별
  • 세계의 R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 시장 매출 vs R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 세계의 제네릭 & 브랜드 매출 비율 : 국가별
  • 시장 매출 vs 제네릭 & 브랜드 매출 비율 : 국가별
  • 소화성 궤양 환자 수 : 국가별
  • 세계의 일반 개업의 수 : 국가별
  • 시장 매출 vs 일반 개업의 수 : 국가별

제10장 아시아태평양 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 중국
  • 인도
  • 일본
  • 호주

제11장 서유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인

제12장 동유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 러시아

제13장 북미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 미국

제14장 남미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 브라질

제15장 중동 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제16장 아프리카 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제17장 경쟁 환경

  • 기업 개요
  • Abbvie
  • Johnson & Johnson
  • Takeda Pharmaceuticals
  • Allergan
  • Ucb

제18장 주요 M&A : 소화기계 의약품 시장

제19장 시장 배경 : 의약품 시장

제20장 의약품 산업의 파이낸셜 마진

제21장 부록

KSA 17.08.07

영문목차

Gastrointestinal Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs market.

Where is the largest and fastest growing market for the gastrointestinal drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.

Scope:

Markets Covered: Antiulcerants; Vitamin And Minerals; Antacids; Antiemetics And Antinauseants ; Antiobesity; Antidiarrhoeals

Companies Mentioned: Takeda Pharmaceticals,Allergan Plc,Novo Nordisk A/S,AstraZeneca Plc,Johnson & Johnson

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Reasons to Purchase:

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

1. Gastrointestinal Drugs Market Characteristics

2. Gastrointestinal Drugs Market Size And Growth

  • 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
    • 2.1.1. Drivers Of The Market
    • 2.1.2. Restraints On The Market
  • 2.2. Forecast Market Growth, Value ($ Billion)
    • 2.2.1. Drivers Of The Market
    • 2.2.2. Restraints On The Market

3. Gastrointestinal Drugs Trends And Strategies

4. Pestle Analysis

  • 4.1. Political
  • 4.2. Economic
  • 4.3. Social
  • 4.4. Technological
  • 4.5. Legal
  • 4.6. Environmental

5. Gastrointestinal Drugs Market Customer Information

6. Gastrointestinal Drugs Market Regional And Country Analysis

  • 6.1. Global Gastrointestinal Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
  • 6.2. Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Region
  • 6.3. Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region
  • 6.4. Global Gastrointestinal Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
  • 6.5. Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Country
  • 6.6. Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Country

7. Gastrointestinal Drugs Market Segmentation

  • 7.1. Global Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

  • 7.2. Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

8. Gastrointestinal Drugs Market Segments

  • 8.1.Antiulcerants

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antiulcerants Market, 2017, By Segment, Value ($ Billion)

  • 8.2.Vitamin And Minerals

a) Market Characteristics

b) Market Trends & Strategies

c) Global Vitamin And Minerals Market, 2017, By Segment, Value ($ Billion)

  • 8.3.Antacids

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antacids Market, 2017, By Segment, Value ($ Billion)

  • 8.4.Antiemetics And Antinauseants

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antiemetics And Antinauseants Market, 2017, By Segment, Value ($ Billion)

  • 8.5.Antiobesity

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antiobesity Market, 2017, By Segment, Value ($ Billion)

  • 8.6.Antidiarrhoeals

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antidiarrhoeals Market, 2017, By Segment, Value ($ Billion)

9. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors

  • 9.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, Global
  • 9.2. Per Capita Average Gastrointestinal Drugs Expenditure, Global

10. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries

  • 10.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, By Country
  • 10.2. Per Capita Average Gastrointestinal Drugs Expenditure, By Country

11. Gastrointestinal Drugs Market Comparison With Industry Metrics

  • 11.1. Global Number Of Pharmacists, 2017, By Country
  • 11.2. Global Gastrointestinal Diseases Market Revenue Versus Number Of Pharmacists, 2017, By Country
  • 11.3. Global Number Of Pharma Enterprises, 2017, By Country
  • 11.4. Global Gastrointestinal Diseases Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
  • 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
  • 11.6. Global Gastrointestinal Diseases Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
  • 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.8. Global Gastrointestinal Diseases Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.9. Prevalent Cases of Peptic Ulcer, 2014, By Country
  • 11.10. Global Number Of General Practitioners 2017, By Country
  • 11.11. Global Gastrointestinal Diseases Market Revenue Versus Number Of General Practitioners, 2017, By Country

12. Asia-Pacific Gastrointestinal Drugs Market

    • 12.1.1. Asia-Pacific Gastrointestinal Drugs Market Overview
    • 12.1.2. Asia-Pacific Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.1.3. Asia-Pacific Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.1.4. Asia-Pacific Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.1.5. Asia-Pacific Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.2. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis
  • 12.3. China Gastrointestinal Drugs Market
    • 12.3.1. China Gastrointestinal Drugs Market Overview
    • 12.3.2. China Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.3.3. China Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.3.4. China Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.3.5. China Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.4. India Gastrointestinal Drugs Market
    • 12.4.1. India Gastrointestinal Drugs Market Overview
    • 12.4.2. India Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.4.3. India Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.4.4. India Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.4.5. India Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.5. Japan Gastrointestinal Drugs Market
    • 12.5.1. Japan Gastrointestinal Drugs Market Overview
    • 12.5.2. Japan Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.5.3. Japan Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.5.4. Japan Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.5.5. Japan Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.6. Australia Gastrointestinal Drugs Market
    • 12.6.1. Australia Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.6.2. Australia Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.6.3. Australia Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.6.4. Australia Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

13. Western Europe Gastrointestinal Drugs Market

    • 13.1.1. Western Europe Gastrointestinal Drugs Market Overview
    • 13.1.2. Western Europe Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.1.3. Western Europe Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.1.4. Western Europe Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.1.5. Western Europe Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.2. Western Europe Gastrointestinal Drugs Market: Country Analysis
  • 13.3. UK Gastrointestinal Drugs Market
    • 13.3.1. UK Gastrointestinal Drugs Market Overview
    • 13.3.2. UK Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.3.3. UK Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.3.4. UK Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.3.5. UK Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.4. Germany Gastrointestinal Drugs Market
    • 13.4.1. Germany Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.4.2. Germany Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.4.3. Germany Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.4.4. Germany Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.5 France Gastrointestinal Drugs Market
    • 13.5.1 France Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.5.2 France Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.5.3. France Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.5.4. France Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.6. Italy Gastrointestinal Drugs Market
    • 13.6.1. Italy Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.6.2. Italy Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.6.3. Italy Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.6.4. Italy Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.7. Spain Gastrointestinal Drugs Market
    • 13.7.1. Spain Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.7.2. Spain Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.7.3. Spain Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.7.4. Spain Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Gastrointestinal Drugs Market

    • 14.1.1. Eastern Europe Gastrointestinal Drugs Market Overview
    • 14.1.2. Eastern Europe Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.1.3. Eastern Europe Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.1.4. Eastern Europe Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 14.1.5. Eastern Europe Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 14.2. Eastern Europe Gastrointestinal Drugs Market: Country Analysis
  • 14.3. Russia Gastrointestinal Drugs Market
    • 14.3.1. Russia Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.3.2. Russia Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.3.3. Russia Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 14.3.4. Russia Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

15. North America Gastrointestinal Drugs Market

    • 15.1.1. North America Gastrointestinal Drugs Market Overview
    • 15.1.2. North America Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.1.3. North America Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.1.4. North America Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 15.1.5. North America Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 15.2. North America Gastrointestinal Drugs Market: Country Analysis
  • 15.3. USA Gastrointestinal Drugs Market
    • 15.3.1. USA Gastrointestinal Drugs Market Overview
    • 15.3.2. USA Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.3.3. USA Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.3.4. USA Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 15.3.5. USA Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

16. South America Gastrointestinal Drugs Market

    • 16.1.1. South America Gastrointestinal Drugs Market Overview
    • 16.1.2. South America Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.1.3. South America Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.1.4. South America Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 16.1.5. South America Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 16.2. South America Gastrointestinal Drugs Market: Country Analysis
  • 16.3. Brazil Gastrointestinal Drugs Market
    • 16.3.1. Brazil Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.3.2. Brazil Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.3.3. Brazil Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 16.3.4. Brazil Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

17. Middle East Gastrointestinal Drugs Market

    • 17.1.1. Middle East Gastrointestinal Drugs Market Overview
    • 17.1.2. Middle East Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 17.1.3. Middle East Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 17.1.4. Middle East Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 17.1.5. Middle East Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

18. Africa Gastrointestinal Drugs Market

    • 18.1.1. Africa Gastrointestinal Drugs Market Overview
    • 18.1.2. Africa Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 18.1.3. Africa Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 18.1.4. Africa Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 18.1.5. Africa Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

19. Gastrointestinal Drugs Market Competitive Landscape

  • 19.1. Company Profiles
  • 19.2. Takeda Pharmaceticals
    • 19.2.1. Overview
    • 19.2.2. Products And Services
    • 19.2.3. Strategy
    • 19.2.4. Financial Performance
  • 19.3. Allergan Plc
    • 19.3.1. Overview
    • 19.3.2. Products And Services
    • 19.3.3. Strategy
    • 19.3.4. Financial Performance
  • 19.4. Novo Nordisk A/S
    • 19.4.1. Overview
    • 19.4.2. Products And Services
    • 19.4.3. Strategy
    • 19.4.4. Financial Performance
  • 19.5. AstraZeneca Plc
    • 19.5.1. Overview
    • 19.5.2. Products And Services
    • 19.5.3. Strategy
    • 19.5.4. Financial Performance
  • 19.6. Johnson & Johnson
    • 19.6.1. Overview
    • 19.6.2. Products And Services
    • 19.6.3. Strategy
    • 19.6.4. Financial Performance

20. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market

21. Market Background: Gastrointestinal Drugs Market

    • 21.1.1. Gastrointestinal Drugs Market Characteristics
    • 21.1.2. Gastrointestinal Drugs Market Historic Growth, Value ($ Billion)
      • 21.1.2.1. Drivers Of The Market
      • 21.1.2.2. Restraints Of The Market
    • 21.1.3. Gastrointestinal Drugs Market Forecast Growth, Value ($ Billion)
      • 21.1.3.1. Drivers Of The Market
      • 21.1.3.2. Restraints Of The Market
    • 21.1.4. Gastrointestinal Drugs Trends And Strategies
  • 21.2. Gastrointestinal Drugs Market Regional And Country Analysis
    • 21.2.1. Global Gastrointestinal Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
    • 21.2.2. Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Region
    • 21.2.3. Gastrointestinal Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
    • 21.2.4. Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Country
    • 21.2.5. Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Segment
    • 21.2.6. Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Country And Segment
  • 21.3. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors
    • 21.3.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, Global
    • 21.3.2. Per Capita Average Gastrointestinal Drugs Expenditure, Global
  • 21.4. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries
    • 21.4.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, By Country
    • 21.4.2. Per Capita Average Gastrointestinal Drugs Expenditure, By Country
  • 21.5. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market

22. Appendix

  • 22.1. NAICS Definitions Of Industry Covered In This Report
  • 22.2. Abbreviations
  • 22.3. Currencies
  • 22.4. Research Inquiries
  • 22.5. The Business Research Company
  • 22.6. Copyright And Disclaimer
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
La Merie Publishing
BCC Research